MJardin Group, Inc. Stock price Canadian Securities Exchange
Equities
MJAR
CA60689X1096
Pharmaceuticals
Sales 2019 | 26.7M 36.33M | Sales 2020 | 11.44M 15.56M | Capitalization | 3.41M 4.64M |
---|---|---|---|---|---|
Net income 2019 | -267M -363M | Net income 2020 | -34M -46.27M | EV / Sales 2019 | 5.55 x |
Net Debt 2019 | 134M 182M | Net Debt 2020 | 164M 223M | EV / Sales 2020 | 14.6 x |
P/E ratio 2019 |
-0.06
x | P/E ratio 2020 |
-0.1
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 92.27% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 21-05-25 |
Edward Jonasson
DFI | Director of Finance/CFO | 55 | 19-10-31 |
Patrick Witcher
BRD | Director/Board Member | - | 19-05-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 21-05-25 |
Blair Jordan
BRD | Director/Board Member | 55 | 21-05-25 |
James Lowe
BRD | Director/Board Member | - | 19-05-05 |
1st Jan change | Capi. | |
---|---|---|
+22.71% | 5.39B | |
-12.40% | 4.67B | |
-5.99% | 3.29B | |
-17.15% | 2.6B | |
-3.06% | 2.52B | |
-6.78% | 1.7B | |
-8.49% | 1.61B | |
+22.27% | 1.63B | |
-5.38% | 1.56B |